Philadelphia University + Thomas Jefferson University

Office of Postdoctoral Affairs
Our Team

JPA Officers 2016

Officers 2017-18

Vilas Desai Vice-President for Nominations and Elections

Vilas Desai

Vilas is from India. After doing his MS in Microbiology, he got his PhD from BITS Pilani, Goa campus, India. Currently, he is a post-doctoral fellow at the Thomas Jefferson University, Jefferson College of Pharmacy. His research work is mainly focused on pancreatic cancer, gliomas and glioblastoma, where he studies the pharmacological effects of combinations of isoflavones and statins on cancer cell proliferation, and the subsequent cell signaling pathways.

Shivsharan Kharatmal, Senior Vice-President

Shivsharan Kharatmal
Senior Vice-President

 Shivsharan is basically a pharmacologist from Mumbai, India. He earned his MS and PhD in the Department of Pharmacology & Toxicology at the National Institute of Pharmaceutical Education & Research (NIPER), S.A.S. Nagar. In 2016, he joined Dr. Ji-Fang Zhang's laboratory as a postdoctoral fellow in the Department of Molecular Physiology & Biophysics at Thomas Jefferson University. His current research is mainly focused on understanding the molecular mechanisms and functional characterization of calcium-activated potassium channels by using patch-clamp electrophysiology.

Megha Verma, Secretary

Megha Verma
Vice President Career Development

Dr. Megha Verma completed her MSc in Molecular Biology at the University of Sheffield, UK and then continued her Doctoral training to complete her PhD thesis “Impact of nicotinic acetylcholine receptor signaling in Alzheimer’s disease” at the Roskamp Institute, Florida.  She joined Thomas Jefferson University in 2015 as a Postdoctoral Research Fellow in the Department of Anatomy, working under Dr. Jay S. Schneider. Her research includes the study of epigenetics of early-life lead exposure and effects on brain development.


Valentina Minieri

Valentina Minieri
Vice-President of Communications

Valentina is originally from Italy. She earned a Bachelor degree and a Master degree in Biotechnology and obtained her PhD in Human Genetics at University of Turin, Italy.  During her PhD she moved at UCL, London, UK aimed to establish new collalorations and complete the last year of her PhD. As a Postdoc she moved to Philadelphia and changed her focus from stem cell studies to human leukemia research. After 3 years at Thomas Jefferson University, she is happily continuing her research focusing on targeting the STAT5 pathway in Ph+ Acute Lymphoblastic Leukemia. 

Rodolfo Thome, Vice-President for Social Affairs

Rodolfo Thome
Vice-President Nominations and Elections

Rodolfo Thome is from Sao Paolo-Brazil, where he earned his Ph.D. in Genetics and Molecular Biology with a major in Immunology from University of Campinas (UNICAMP). He joined Dr. Rostami’s lab as a post-doc fellow at Jefferson Hospital of Neuroscience early 2016. His research interests are (1) the study of the development and function of dendritic cells and (2) the development of cell/cytokine-based therapies in Multiple Sclerosis using the Experimental Autoimmune Encephalomyelitis model of MS.

Elena Irollo

Elena Irollo
Vice-President Social Affairs

No Bio Available



Kalyan Golla, Treasurer

Kalyan Golla

Kalyan is from India where he earned his BS in Pharmacy. He earned his MS from Dublin institute of Technology, Ireland and  his PhD from Royal College of Surgeon in Ireland. Currently he is a postdoctoral fellow in Hematology department in Thomas Jefferson. His research work is mainly focused on identification of role of mitotic protein in platelet function and role of tight junction proteins in endothelial cell function.

Lauren Klayman

Lauren Klayman

Lauren earned her BS in Biochemistry/Biophysics from Rensselaer Polytechnic Institute and her PhD from Thomas Jefferson University in the lab of Dr. Phil Wedegaertner. Currently, she is a Postdoctoral Research Fellow in Cancer Biology working with Dr. Elda Grabocka. Her work focuses on identifying Stress Granule components and signaling pathways involved in Pancreatic Cancer.